References

  1. Lieberman P, Kaliner MA, Wheeler WJ. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Curr Med Res Opin. 2005;21(4):611–618.
  2. ASTEPRO [package insert]. Somerset, NJ: Meda Pharmaceuticals Inc; 2009.
  3. van Bavel J, Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(5):512–518.
  4. Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(6):628–633.
  5. Shah S, Wheeler W. Efficacy and safety of azelastine nasal spray 0.15% and azelastine nasal spray 0.10% in patients with seasonal allergic rhinitis. Presented at: Eastern Allergy Conference; May 6-9, 2010; Palm Beach, FL. Abstract.

AST-12-0004